The morphological growth patterns of colorectal liver metastases are prognostic for overall survival

Modern Pathology

Volumn 27, Issue 12, 2014, Pages 1641-1648

  Nielsen, Kåre ^a   Rolff, Hans C ^a,b   Eefsen, Rikke L ^a,b   Vainer, Ben ^a  

^a Rigshospitalet   (Denmark)

^b FINSEN LABORATORY   (Denmark)

Author keywords

colorectal cancer; growth pattern; histopathology; liver; metastasis; prognosis; survival

Indexed keywords

ANTINEOPLASTIC AGENT; EOSIN; HEMATOXYLIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER MORPHOLOGY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CELL DENSITY; CELL INFILTRATION; COLORECTAL CARCINOMA; COLORECTAL LIVER METASTASIS; EXPLORATORY RESEARCH; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; TISSUE SECTION; TUMOR DIFFERENTIATION; ADENOCARCINOMA; COLORECTAL TUMOR; KAPLAN MEIER METHOD; LIVER TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SECONDARY; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; YOUNG ADULT;

EID: 84927175076     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2014.4     Document Type: Article

References (24)

1. Vermeulen PB, Colpaert C, Salgado R, et al. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol 2001;195:336-342.
2. Stessels F, van den Eynden G, van der Auwera I, et al. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a nonangiogenic growth pattern that preserves the stroma and lacks hypoxia. Br J Cancer 2004;90:1429-1436.
3. Van den Eynden GG, Bird NC, Majeed AW, et al. The histological growth pattern of colorectal cancer liver metastases has prognostic value. Clin Exp Metastasis 2012;29:541-549.
4. Eefsen RL, Van den Eynden GG, Hyer-Hansen G, et al. Histopathological growth pattern, proteolysis and angiogenesis in chemonaive patients resected for multiple colorectal liver metastases. J Oncol 2012; 2012:907971.
5. Illemann M, Bird N, Majeed A, et al. Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases. Int J Cancer 2009;124:1860-1870.
6. Nagashima I, Oka T, Hamada C, et al. Histopathological prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer. Am J Gastroenterol 1999;94:739-743.
7. Ambiru S, Miyazaki M, Isono T, et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 1999;42:632-639.
8. Lunevicius R, Nakanishi H, Ito S, et al. Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer. J Cancer Res Clin Oncol 2001;127:193-199.
9. Morino T, Tanaka J, Tobe T. Clinico-pathological features of liver metastases from colorectal cancer in relation to prognosis. Nihon Geka Hokan 1991;60:154-164.
10. Ohlsson B, Stenram U, Tranberg KG. Resection of colorectal liver metastases: 25-year experience.World J Surg 1998;22:268-276.
11. Okano K, Yamamoto J, Kosuge T, et al. Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma.Clinicopathologic study of 152 first resection cases. Cancer 2000;89:267-275.
12. Weber JC, Nakano H, Bachellier P, et al. Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? Am J Surg 2001;182:81-88.
13. Yamamoto J, Shimada K, Kosuge T, et al. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 1999;86: 332-337.
14. Sardari Nia P, Colpaert C, Blyweert B, et al. Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer. Br J Cancer 2004;91:1293-1300.
15. Sardari Nia P, Van Marck E, Weyler J, et al. Prognostic value of a biologic classification of non-small-cell lung cancer into the growth patterns along with other clinical, pathological and immunohistochemical factors. Eur J Cardiothorac Surg 2010;38:628-636.
16. Hautekeete ML, Geerts A. The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch 1997;430:195-207.
17. Li D, Friedman SL. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol 1999;14:618-633.
18. Théret N, Musso O, Turlin B, et al. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology 2001;34:82-88.
19. Bissell DM. Chronic liver injury, TGF-beta, and cancer. Exp Mol Med 2001;33:179-190.
20. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669.
21. Conti JA, Kendall TJ, Bateman A, et al. The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via av integrin ligation. Clin Cancer Res 2008;14:6405-6413.
22. Terayama N, Terada T, Nakanuma Y. Histologic growth patterns of metastatic carcinomas of the liver. Jpn J Clin Oncol 1996;26:24-29.
23. Paku S, Kopper L, Nagy P. Development of the vasculature in "pushing-type" liver metastases of an experimental colorectal cancer. Int J Cancer 2005;115:893-902.
24. Sadanandam A, Lyssiotis CA, Homicsko K, et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med 2013;19:619-625.